CTSN Embolic Protection Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 842 participants.
Also called NCT06027788
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 842 participants
- Registry
-
NCT06027788
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06027788. Randomized; single masking; primary purpose prevention. Start 2023-09-18 (actual); primary completion 2027-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CTSN Embolic Protection Trial
- Acronym
- EMPRO
- Condition
- Delirium
- Condition
- Ischemic Stroke
- Condition
- Acute Kidney Injury
- Condition
- Heart Valve Disease
- Condition
- Coronary Artery Disease
- Intervention (Device)
- CardioGard Embolic Protection Cannula
- Intervention (Device)
- Standard Aortic Cannula
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct06027788- Content hash
5c3d26b4ef3d401065cfe035f77cc34cbaefb3fc5c5e499cc7fa1be9ee6ccb06